The Dow Jones closed higher by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
SAB Biotherapeutics
The Trade: SAB Biotherapeutics, Inc. (NASDAQ: SABS) Executive Chairman Samuel J Reich acquired a total of 11,000 shares an average price of $0.89. To acquire these shares, it cost around $9,842.
What's Happening: SAB Biotherapeutics announced that the first HUMAN trial participants (Fully HUman anti-thymocyte biologic in a first-in-MAN clinical study) have been dosed in Australia.
What SAB Biotherapeutics Does: SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused ...